Slingshot members are tracking this event:

AstraZeneca's(AZN) Lynparza(olaparib) in metastatic breast cancer PDUFA date is set for the first quarter of 2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
AZN Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Lynparza, Metastatic Breast Cancer, Her2, Brca Gene Mutation, Olaparib, Parp Inhibitor